Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.28 $5.69 Thursday, 9th May 2024 MBRX stock ended at $4.78. This is 1.70% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.54% from a day low at $4.61 to a day high of $5.05.
90 days $0.400 $6.23
52 weeks $0.338 $6.23

Historical Moleculin Biotech Inc prices

Date Open High Low Close Volume
Aug 29, 2023 $0.560 $0.580 $0.560 $0.572 28 731
Aug 28, 2023 $0.571 $0.600 $0.560 $0.560 41 644
Aug 25, 2023 $0.560 $0.571 $0.560 $0.562 57 389
Aug 24, 2023 $0.560 $0.560 $0.553 $0.560 35 595
Aug 23, 2023 $0.560 $0.571 $0.553 $0.560 41 146
Aug 22, 2023 $0.550 $0.571 $0.550 $0.560 42 386
Aug 21, 2023 $0.560 $0.571 $0.550 $0.550 74 928
Aug 18, 2023 $0.571 $0.571 $0.551 $0.553 107 480
Aug 17, 2023 $0.592 $0.600 $0.570 $0.576 22 338
Aug 16, 2023 $0.609 $0.610 $0.560 $0.583 39 831
Aug 15, 2023 $0.620 $0.628 $0.590 $0.600 42 709
Aug 14, 2023 $0.618 $0.640 $0.593 $0.622 62 944
Aug 11, 2023 $0.580 $0.635 $0.580 $0.618 90 671
Aug 10, 2023 $0.600 $0.659 $0.590 $0.630 69 455
Aug 09, 2023 $0.630 $0.630 $0.600 $0.600 16 628
Aug 08, 2023 $0.600 $0.630 $0.600 $0.603 64 162
Aug 07, 2023 $0.610 $0.658 $0.580 $0.621 112 956
Aug 04, 2023 $0.630 $0.640 $0.600 $0.605 51 584
Aug 03, 2023 $0.654 $0.660 $0.610 $0.620 59 491
Aug 02, 2023 $0.648 $0.648 $0.630 $0.645 23 068
Aug 01, 2023 $0.637 $0.674 $0.632 $0.660 32 438
Jul 31, 2023 $0.672 $0.700 $0.633 $0.633 110 122
Jul 28, 2023 $0.660 $0.680 $0.650 $0.661 18 081
Jul 27, 2023 $0.660 $0.670 $0.650 $0.650 34 774
Jul 26, 2023 $0.680 $0.680 $0.646 $0.679 21 291
Click to get the best stock tips daily for free!

About Moleculin Biotech Inc

Moleculin Biotech Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial fo... MBRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT